LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Home・Lista de Ações・Pfizer

Pfizer

Fechado

SetorSaúde

25.69 1.38

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

25.35

Máximo

25.98

Indicadores-chave
By Trading Economics
Rendimento	4.3B 2.7B
Vendas	-3.1B 14B
P/E Médio do Setor	19.565 49.888
EPS	0.47
Rendimento de Dividendos	6.57
Margem de lucro	18.656
Funcionários	75,000
EBITDA	4.5B 5.2B

Recomendações
By TipRanks
Recomendações	Neutro
Previsão para 12 meses	+15.11% upside

Dividendos
By Dow Jones
Rendimento de Dividendos Médio do Setor	6.57% 2.38%
Próximos Ganhos	4 de ago. de 2026
Próxima data de dividendos	12 de jun. de 2026
Próxima data de ex-dividendo	24 de jul. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-3.5B 146B
Abertura anterior	24.31
Fecho anterior	25.69

Sentimento de Notícias

By Acuity

45%

55%

144 / 344 Ranking em Healthcare

Pfizer Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

5 de mai. de 2026, 11:31 UTC

Ganhos

Pfizer 1Q Revenue Rises But Profit Falls Amid Boosted R&D Spending

5 de mai. de 2026, 18:12 UTC

Ganhos

BioNTech to Slash 22% of Workforce as Losses Widen. The Stock Falls. -- Barrons.com

5 de mai. de 2026, 13:54 UTC

Ganhos

BioNTech to Slash 25% of Workforce as Losses Widen. The Stock Falls. -- Barrons.com

5 de mai. de 2026, 12:35 UTC

Ganhos

Pfizer Posts Better-Than-Expected Revenue, Profit -- WSJ

5 de mai. de 2026, 11:06 UTC

Ganhos

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates -- Barrons.com

5 de mai. de 2026, 10:47 UTC

Ganhos

Pfizer: Current Financial Guidance Doesn't Anticipate Any Stock Buybacks in 2026 >PFE

5 de mai. de 2026, 10:47 UTC

Ganhos

Pfizer Still Sees 2026 Adjusted R&D Expenses $10.5B-$11.5B >PFE

5 de mai. de 2026, 10:46 UTC

Ganhos

Pfizer 1Q Revenue of Launched, Acquired Products Rose 22% Operationally >PFE

5 de mai. de 2026, 10:46 UTC

Ganhos

Pfizer 1Q Revenue Rose 7% Operationally Excluding Contributions From Comirnaty, Paxlovid >PFE

5 de mai. de 2026, 10:45 UTC

Ganhos

Pfizer Reaffirms 2026 Guidance >PFE

5 de mai. de 2026, 10:45 UTC

Ganhos

Pfizer Sees FY Rev $59.5B-$62.5B >PFE

5 de mai. de 2026, 10:45 UTC

Ganhos

Pfizer Sees FY Adj EPS $2.80-Adj EPS $3.00 >PFE

5 de mai. de 2026, 10:45 UTC

Ganhos

Pfizer 1Q Rev $14.5B >PFE

5 de mai. de 2026, 10:45 UTC

Ganhos

Pfizer 1Q EPS 47c >PFE

5 de mai. de 2026, 10:45 UTC

Ganhos

Pfizer 1Q Net $2.69B >PFE

5 de mai. de 2026, 10:45 UTC

Ganhos

Pfizer 1Q Adj EPS 75c >PFE

5 de mai. de 2026, 10:36 UTC

Ações em Alta

Stocks to Watch: Palantir, HSBC, Intel, AMD -- WSJ

23 de abr. de 2026, 21:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

1 de abr. de 2026, 20:07 UTC

Aquisições, Fusões, Aquisições de Empresas

Why 2026 Is Biotech's Comeback Year -- Barrons.com

11 de mar. de 2026, 11:02 UTC

Conversa de Mercado

Sanofi, Regeneron's Eczema Drug Might Face Competition From Pfizer -- Market Talk

10 de mar. de 2026, 12:50 UTC

Ganhos

BioNTech Stock Plunges 17% After Earnings. Why the Drugmaker Faces a Perfect Storm. -- Barrons.com

10 de mar. de 2026, 11:18 UTC

Ganhos

BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock. -- Barrons.com

9 de mar. de 2026, 09:43 UTC

Ações em Alta

Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer -- WSJ

10 de fev. de 2026, 21:51 UTC

Ganhos

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 de fev. de 2026, 21:17 UTC

Ganhos

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

3 de fev. de 2026, 21:36 UTC

Ganhos

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 de fev. de 2026, 19:56 UTC

Ganhos

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 de fev. de 2026, 19:46 UTC

Ganhos

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 de fev. de 2026, 17:35 UTC

Ganhos

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 de fev. de 2026, 17:30 UTC

Ganhos

These Stocks Are Today's Movers: Palantir, PayPal, Novo Nordisk, Pfizer, Merck, AMD, Gartner, and More -- Barrons.com

Comparação entre Pares

Variação de preço

Pfizer Previsão

Preço-alvo

By TipRanks

15.11% parte superior

Previsão para 12 meses

Média 29.17 USD 15.11%

Máximo 36 USD

Mínimo 25 USD

Com base em 22 analistas de Wall Street que oferecem metas de preço de 12 meses para Pfizer - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

22 ratings

Comprar

Manter

Vender

Com base em 22 analistas que deram avaliações de ações para Pfizer - Dist nos últimos 3 meses.

Sentimento

By Acuity

144 / 344 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.